The Service Line
The United States lost its measles elimination status on Tuesday, and obstetric practices are the next place the cost shows up. The Pan American Health Organization made the loss official November 17, according to ABC News, after the country failed to break a chain of transmission that began in January 2025. The Centers for Disease Control and Prevention counts 5,412 confirmed cases in 2026 as of November 12, against 2,289 in all of 2025. The American College of Obstetricians and Gynecologists (ACOG) said in a statement reported by Contemporary OB/GYN that cases are rising among pregnant patients and that some of the first congenital measles cases in decades have appeared. The measles, mumps and rubella (MMR) vaccine is a live vaccine and cannot be given in pregnancy, so the window is before conception (wait 28 days after a dose) or before hospital discharge after delivery. Exposed, non-immune pregnant patients need immune globulin within 6 days. So what: practices should audit how many prenatal charts lack documented measles immunity, stock or arrange immune globulin access, and build postpartum MMR into discharge order sets, because every one of those steps is unpaid labor under a bundle that is about to disappear. Confidence: High on the case counts and the clinical rules (CDC figures and ACOG guidance as reported); Med on the primary record, because I read the trade report of ACOG’s statement rather than the statement itself.
Reimbursement
Medicare’s 2027 fee schedule cuts the conversion factor 2.31% for most physicians, and OB visits will be paid at the new, lower rate from the first prenatal visit. The final rule, released November 4 and effective January 1, sets the conversion factor at $32.6286 for clinicians outside advanced payment models, down from $33.4009, and $32.9548 for qualifying participants, down 1.83%, according to Holland & Knight’s summary. The drivers are the expiration of a temporary 2.5% increase and a 0.12% budget neutrality cut. BakerHostetler confirms the maternity piece: Medicare adopts the American Medical Association’s unbundled maternity codes and declined to finalize the bundled G-codes, though it may revisit them. Separately, the final rule pays a same-day office visit billed with modifier 25 at 80% when it accompanies a procedure with no global period, not the 50% originally proposed. So what: any OB-GYN practice that bills a visit alongside an in-office procedure such as an IUD insertion should model that 20% haircut, and every wRVU-based comp model should be rerun at $32.63, not $33.40. Confidence: High on the conversion factors (two law-firm summaries agree); Med on the application to OB procedures, which is my inference from the 0-day-global rule, since neither summary names obstetrics. I did not retrieve the CMS rule text.
Enforcement
Nothing obstetrics-specific surfaced from the Justice Department, the HHS Office of Inspector General (OIG) or state Medicaid fraud units this window. One date to hold: OIG’s June audit of Medicaid managed-care maternal health network lists carries a CMS implementation update due December 10, and the OIG report found about a quarter of listed maternal health providers said they were not in network.
Who’s Buying
A national laboratory chain is paying $210 million for a prenatal genetic testing business its seller was already shrinking. Labcorp agreed to buy Myriad Genetics’ prenatal unit, which includes the Prequel, Foresight, SneakPeek and FirstGene tests, for $210 million in cash plus inventory, per Labcorp’s announcement of the definitive agreement. Labcorp expects roughly $160 million in first-year revenue and a close by early 2027, and MedTech Dive reports Myriad’s prenatal revenue fell 16% in the second quarter on 9% lower volume as it refocuses on cancer testing. So what: practices that draw samples for these tests are about to deal with a new counterparty, so check the assignment clauses in lab contracts and keep any draw-fee or space arrangements at documented fair market value, since genetic-testing remuneration is the standing Justice Department theory in this specialty. Confidence: High on terms (company release and trade report agree); Low on any change to practice-level pricing, which has not been announced.
Clinical Policy
Labor and delivery closures continue into the winter, and the next ones are already dated. MaineHealth’s Lincoln Hospital ends births December 18, per WTOP, and Southeast Iowa Regional Medical Center in Fort Madison will end inpatient labor and delivery after December 31, according to Becker’s Hospital Review, which also keeps a running tally of at least 26 maternity closures in 2026. The Center for Healthcare Quality and Payment Reform’s rural maternity tracker counts 146 rural hospitals that stopped delivering or announced plans to since the end of 2020, as of July. So what: Medicaid pays for about 40% of U.S. births, so the managed-care rate a unit gets under the new codes in January is a survival variable for small units. Confidence: Med; the Iowa item and the 26 count come from Becker’s, which my fetcher could not open this run, so I relied on search excerpts.
The Operator Metric
The number to track this week: $32.6286, the 2027 Medicare conversion factor for most physicians, down 2.31%. It multiplies every relative value unit your practice bills, including each of the separately billed prenatal and postpartum visits that replace the global fee on January 1. Many Medicaid managed-care plans and commercial contracts key off the Medicare fee schedule, so a lower factor flows into more than Medicare payments. Compare it against the $33.4009 your 2026 comp model assumes and rerun visit-volume scenarios before year end. Confidence: High on the figure (Holland & Knight, BakerHostetler); Med on how far commercial contracts track it.
Free. One email a day at 6pm your time, or one summary every Friday. Switch or stop anytime.